Company Filing History:
Years Active: 2020
Title: Alan David Michelson: Innovator in Thrombosis Research
Introduction
Alan David Michelson is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of medical research, particularly in understanding blood clot formation. His innovative work has led to the development of a patented method that enhances the understanding of thrombosis.
Latest Patents
Michelson holds a patent for "Methods, systems, and compositions for determining blood clot formation, and uses thereof." This method is directed to determining a thrombosis function and includes flowing a fluid sample over a surface having a fixed endothelial cell monolayer. The method further includes stimulating the fixed endothelial cell monolayer to induce the formation of a clot, which occurs via interaction between the fixed endothelial cell monolayer and the fluid sample. In response to the clot formation, the method includes determining a thrombosis function associated with the fluid sample and the fixed endothelial cell monolayer. He has 1 patent to his name.
Career Highlights
Throughout his career, Michelson has worked with prestigious institutions such as Harvard College and Children's Medical Center Corporation. His research has been pivotal in advancing the understanding of thrombosis and its implications in various medical conditions.
Collaborations
Michelson has collaborated with notable professionals in his field, including Donald Elliot Ingber and Abhishek Jain. These collaborations have further enriched his research and contributed to the advancement of thrombosis studies.
Conclusion
Alan David Michelson's innovative work in thrombosis research has made a significant impact in the medical field. His patented methods provide valuable insights into blood clot formation, showcasing his dedication to advancing medical science.